Adjunctive yokukansan treatment improved cognitive functions in a patient with schizophrenia.
Adjunctive yokukansan treatment improved cognitive functions in a patient with schizophrenia.
复制标题
抑肝散辅助治疗改善了精神分裂症患者的认知功能。
DOI：
10.1176/appi.neuropsych.12070166
复制
发表时间：
2013
期刊：
影响因子：
--
通讯作者：
Uchitomi Y.
中科院分区：
文献类型：
--
作者：
Sakamoto S;Ujike H;Takaki M;Mizuki Y;Okahisa Y;Kodama M;Uchitomi Y.
致编辑：抑肝散是一种传统的亚洲草药，据随机对照试验报道，它对痴呆症的行为和心理症状安全有效，在日本广泛用于治疗痴呆症患者。 1 最近的一项开放标签研究表明，在难治性精神分裂症中辅助使用抑肝散可改善精神分裂症的阳性和阴性症状。 2 在本报告中，我们介绍了一个精神分裂症病例，其中辅助抑肝散治疗显着改善了严重的认知功能障碍。
To the Editor: Yokukansan, a traditional Asian herbal medicine, is reported to be safe and effective for behavioral and psychological symptoms of dementia in randomized, controlled trials, and is widely prescribed for patients with dementia in Japan. 1 A recent openlabel study indicates that adjunctive yokukansan administration in treatment-resistant schizophrenia improved the positive and negative symptoms of schizophrenia. 2 In this report, we present a case of schizophrenia in which adjunctive yokukansan treatment dramatically improved severe cognitive dysfunction.